// App-Quantinova.ai

4304 : Prevalence and triggers of drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a cancer patient cohort

Researchers

Presenter

  • Nancy K. Gillis

Principal Investigators

  • Gillian C. Bell

  • Howard L. McLeod

  • Amy J. Brandt

Medical Centers

  • University of North Carolina, Chapel Hill, NC

  • Mission Health, Asheville, NC

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Stevens Johnson syndrome

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Carbamazepine

  • Allopurinol

  • Lamotrigine

  • sulfonamide Vaginal

  • Nevirapine

  • Dilantin suspension

  • Meloxicam

  • Tenoxicam

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A